Urol Res Pract. 2026 Jun 11;52:1-8. doi: 10.5152/tud.2026.25137.
ABSTRACT
OBJECTIVE: To evaluate the clinical impact of a modified daytime double-J (DJ) stent removal model based on comfort-oriented medical care on patient pain, anxiety, procedural efficiency, and satisfaction.
METHODS: Between January 2024 and June 2025, 160 patients undergoing ureteroscopy or percutaneous nephrolithotomy requiring DJ stent removal were randomly assigned to a comfort group (n = 80) or a conventional group (n = 80). The comfort group received structured preoperative education, intravenous sedation combined with urethral local anesthesia, pressurized irrigation-assisted cystoscopic removal, and postoperative follow-up. The conventional group underwent traditional outpatient cystoscopic stent removal. Outcomes included Visual Analog Scale (VAS) pain scores, Self-Rating Anxiety Scale (SAS) scores, stent removal time, patient satisfaction, and postoperative complications.
RESULTS: The comfort group reported significantly lower 24-hour VAS pain scores than the conventional group (2.6 ± 0.9 vs. 5.5 ± 1.0, P < .001). Baseline SAS scores were significantly lower in the comfort group than in the conventional group (30.2 ± 5.7 vs. 46.2 ± 7.0, P < .001), and postoperative SAS scores were 28.4 ± 4.7 vs. 42.0 ± 6.8, both P < .001. Stent removal time was shorter in the comfort group (1.90 ± 0.35 minutes vs. 2.20 ± 0.50 minutes, P = .014). Satisfaction scores and satisfaction rates were higher in the comfort group (4.6 ± 0.5 vs. 3.6 ± 0.7, 96.2% vs. 70.0%, P < .01). The 24-hour postoperative complication rate was low and not statistically significant (2.5% vs. 2.5%, P > .05).
CONCLUSION: The comfort-oriented daytime stent removal model significantly reduces procedural pain and anxiety while improving patient satisfaction without increasing short-term complications. Cite this article as: Xu X, Wu S, Yu Q, Tang R. A randomized study of a comfort-oriented daytime double-J stent removal protocol: effects on pain, anxiety, and patient satisfaction. Urol Res Pract. 2026, 52, 0137, doi: 10.5152/tud.2026.25137.
PMID:42364215 | DOI:10.5152/tud.2026.25137
